Literature DB >> 3917747

Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy.

M Faryna, J Nauman, A Gardas.   

Abstract

Antibodies that reacted with plasma membranes of human eye muscle but showed no binding to plasma membranes of human skeletal muscle were identified in serum of patients with Graves' ophthalmopathy. Rabbit antithyroglobulin serum at a dilution of 1 X 10(-3) to 20 X 10(-3) had no effect on the binding of these antibodies to eye muscle membrane antigens. There was no correlation between antihuman eye muscle plasma membrane antibodies and antihuman thyroid membrane antibodies or antibodies against thyroglobulin. It is suggested that specific antibodies against eye muscle membranes are present in Graves' ophthalmopathy and that this disease might represent a distinct autoimmune disorder.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917747      PMCID: PMC1417914          DOI: 10.1136/bmj.290.6463.191

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  11 in total

1.  Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane.

Authors:  J Konishi; M M Herman; J P Kriss
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

2.  The binding of thyrotropin to isolated bovine thyroid plasma membranes.

Authors:  S M Amir; T F Carraway; L D Kohn; R J Winand
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

3.  Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos.

Authors:  P Mashieu; R Winand
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

4.  Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association.

Authors:  S C Werner
Journal:  J Clin Endocrinol Metab       Date:  1977-01       Impact factor: 5.958

5.  New simple and sensitive method of estimation of anti-thyroid-plasma-membranes antibodies in serum of patients with autoimmune thyroid diseases.

Authors:  A Gardas; B Czarnocka; J Nauman
Journal:  Endokrynol Pol       Date:  1982       Impact factor: 1.582

6.  A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.

Authors:  P Kendall-Taylor; S Atkinson; M Holcombe
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-21

7.  Simple and sensitive method for estimation of antithyroid plasma membrane antibodies in the serum of patients with autoimmune thyroid diseases; comparison with other assays.

Authors:  A Gardas; B Czarnocka; M Faryna; G Adler; A Lewartowska; K Krawczyński; J Nauman
Journal:  Acta Endocrinol (Copenh)       Date:  1984-04

8.  The presence of autoantibodies directed to thyroid plasma membrane antigens in sera of patients with thyroid disorders, estimated by the reaction with labelled protein A.

Authors:  A Gardas; B Czarnocka; J Nauman
Journal:  Acta Endocrinol (Copenh)       Date:  1984-04

9.  Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test.

Authors:  R E Munro; L Lamki; V V Row; R Volpé
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

10.  Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy.

Authors:  K Kodama; H Sikorska; P Bandy-Dafoe; R Bayly; J R Wall
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

View more
  14 in total

Review 1.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

2.  Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy.

Authors:  J R Wall; H Triller; A Boucher; N F Bernard; M Salvi; M Ludgate
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

3.  T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy.

Authors:  A P Weetman; P Fells; B Shine
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

4.  Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.

Authors:  W M Wiersinga; T Smit; R van der Gaag; L Koornneef
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

5.  Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?

Authors:  J I Kiljanski; K Peele; I Stachura; J Pickeral; C Stolarski; J S Kennerdell; J R Wall
Journal:  J Endocrinol Invest       Date:  1997-11       Impact factor: 4.256

6.  IgA autoantibodies against human eye muscle antigen detected by western blotting and immunohistochemical methods in Graves' disease.

Authors:  I Molnár; V Kaczur; A Boros; G Krajczár; C Balázs
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

7.  Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.

Authors:  M Mengistu; E Laryea; A Miller; J R Wall
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

8.  Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

Authors:  Hooshang Lahooti; Kishan R Parmar; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2010-05-14

9.  A study of the binding of Graves' immunoglobulins to orbital antigens.

Authors:  K Banovac; S Levis; S F Byrne
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

10.  Combined irradiation and low-dose cyclophosphamide in the treatment of Graves' ophthalmopathy.

Authors:  R Teoh; J Woo
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.